- Home
- ADMA vs RYN Comparison
ADMA vs RYN Comparison
Compare ADMA & RYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADMA
- RYN
- Stock Information
- Founded
- ADMA 2004
- RYN 1926
- Country
- ADMA United States
- RYN United States
- Employees
- ADMA N/A
- RYN N/A
- Industry
- ADMA Biotechnology: Biological Products (No Diagnostic Substances)
- RYN Real Estate Investment Trusts
- Sector
- ADMA Health Care
- RYN Real Estate
- Exchange
- ADMA Nasdaq
- RYN Nasdaq
- Market Cap
- ADMA 3.7B
- RYN 3.7B
- IPO Year
- ADMA N/A
- RYN N/A
- Fundamental
- Price
- ADMA $15.05
- RYN $24.72
- Analyst Decision
- ADMA Strong Buy
- RYN Hold
- Analyst Count
- ADMA 3
- RYN 4
- Target Price
- ADMA $27.67
- RYN $28.00
- AVG Volume (30 Days)
- ADMA 3.1M
- RYN 1.1M
- Earning Date
- ADMA 11-06-2025
- RYN 11-05-2025
- Dividend Yield
- ADMA N/A
- RYN 11.70%
- EPS Growth
- ADMA 469.09
- RYN 389.17
- EPS
- ADMA 0.85
- RYN 4.92
- Revenue
- ADMA $474,174,000.00
- RYN $1,239,943,000.00
- Revenue This Year
- ADMA $21.17
- RYN N/A
- Revenue Next Year
- ADMA $26.03
- RYN $2.18
- P/E Ratio
- ADMA $17.41
- RYN $5.02
- Revenue Growth
- ADMA 43.58
- RYN 40.53
- 52 Week Low
- ADMA $13.50
- RYN $21.84
- 52 Week High
- ADMA $25.67
- RYN $32.88
- Technical
- Relative Strength Index (RSI)
- ADMA 47.74
- RYN 40.25
- Support Level
- ADMA $14.35
- RYN $24.42
- Resistance Level
- ADMA $15.60
- RYN $25.29
- Average True Range (ATR)
- ADMA 0.52
- RYN 0.65
- MACD
- ADMA 0.13
- RYN -0.16
- Stochastic Oscillator
- ADMA 65.17
- RYN 20.71
About ADMA ADMA Biologics Inc
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
About RYN Rayonier Inc. REIT
Rayonier owns and manages over 2 million acres of timberland in the United States. It is one the largest private landowners in North America. Rayonier is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities.